SODIUM THIOSULFATE INJECTION, USP 25% ML VIAL

LOSARTAN POTASSIUM, USP

EX-CELL(TM) CD CHO (MODIFIED), SERUM-FREE MEDIUM, CHEMICALLY DEFINED W/O GLUCOSE, W/O L-GLUTAMINE, W/O HYPOXANTHINE, W/O THYMIDINE

PRODUCT 15149-28

CONCEPT1 DRY POWDER INHALATION DEVICE

COMPONENTS FOR PHARMACEUTICAL APPLICATIONS

LAMINATED TUBES FOR PHARMACEUTICAL USE

DOCETAXEL TRIHYDRATE

TOPOTECAN HYDROCHLORIDE

TOBRAMYCIN (NON-STERILE, BULK FORM)

FENOFIBRATE INTERMEDIATE DRUG SUBSTANCE

L(+)LACTIC ACID

PRAVASTATIN SODIUM USP

KETOROLAC TROMETHAMINE ACTIVE PHARMACEUTICAL INGREDIENT

OXYCODONE HYDROCHLORIDE (MS PROCESS)

CEFDINIR HYDRATE

SILICA GEL DESICCANT BAG WITH TYVEK(R) ENVELOPE

CAPTISOL � CMC

QUETIAPINE FUMARATE USP

FLUCONAZOLE USP

TERCONAZOLE

Flavin Mononucleotide

C17H21N4O9P

Triflupromazine

C18H19F3N2S

IMIQUIMOD

Paclitaxel photodegradant

Hydroxy Pioglitazone M-IV

VENTRUX ME30 DRUG SUBSTANCE

PHARMEDR BPT BIOCOMPATIBLE TUBING

IRINOTECAN HYDROCHLORIDE USP (NON-STERILE BULK) DRUG SUBSTANCE

DORZOLAMIDE HYDROCHLORIDE

RPP #26-1220 - PACKAGING MATERIAL

SULINDAC